SHOX2 DNA Methylation is a Biomarker for the diagnosis of lung cancer based on bronchial aspirates

<p>Abstract</p> <p>Background</p> <p>This study aimed to show that SHOX2 DNA methylation is a tumor marker in patients with suspected lung cancer by using bronchial fluid aspirated during bronchoscopy. Such a biomarker would be clinically valuable, especially when, following the first bronchoscopy,...

Descrición completa

Detalles Bibliográficos

Principais autores:	Liloglou Triantafillos, Wille Ulrike, Weickmann Sabine, Tetzner Reimo, Distler Jürgen, Lewin Jörn, Seemann Stefanie, Flemming Nadja, Seegebarth Anke, Schlegel Thomas, Kneip Christoph, Dietrich Dimo, Liebenberg Volker, Schmidt Bernd, Raji Olaide, Walshaw Martin, Fleischhacker Michael, Witt Christian, Field John K
Formato:	Artigo
Idioma:	Inglês
Publicado:	BMC 2010-11-01
Series:	BMC Cancer
Acceso en liña:	http://www.biomedcentral.com/1471-2407/10/600
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!